Physician profile
Sunil Modi
NPI 1811195365
$4,271.02
in general payments reported to CMS, 2019-2025
38 companies · $1,247 in 2025
The $1,247 reported for 2025 was more than what 89% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $225 · 2020: $295 · 2021: $521 · 2022: $559 · 2023: $650 · 2024: $772 · 2025: $1,247.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,670.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,669.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $550.66 | 2020-2025 | Farxiga, Airsupra, Breztri |
| Lilly USA, LLC | $538.48 | 2019-2025 | Mounjaro, Jardiance, Emgality |
| Abbott Laboratories | $426.28 | 2019-2025 | Freestyle Libre 3, Proclaim |
| Novo Nordisk INC | $341.04 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Dexcom, INC. | $267.80 | 2024-2025 | Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor, Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $224.57 | 2020-2025 | Jardiance |
| Abbvie INC. | $201.82 | 2021-2025 | |
| Kowa Pharmaceuticals America, INC. | $154.58 | 2025 | Zoryve |
| Merck Sharp & Dohme LLC | $143.85 | 2020-2022 | |
| Glaxosmithkline, LLC. | $140.95 | 2024-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Bayer Healthcare Pharmaceuticals INC. | $121.38 | 2024-2025 | |
| Pfizer INC. | $118.88 | 2023-2024 | |
| Redhill Biopharma INC. | $116.79 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $108.61 | 2023 | Spravato |
| Phathom Pharmaceuticals, INC. | $100.08 | 2024-2025 | Voquezna |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunil Modi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.